Home › Funds › NAN FUNG TRINITY (HK) Ltd › BCAX
NAN FUNG TRINITY (HK) Ltd position in BCAX
BICARA THERAPEUTICS INC · Health Care
NAN FUNG TRINITY (HK) Ltd reported holding 427,885 shares of BCAX (BICARA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 0.76% of its reported portfolio and ranking #44 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed BCAX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NAN FUNG TRINITY (HK) Ltd's BCAX position evolved
NAN FUNG TRINITY (HK) Ltd first disclosed a stake in BCAX in Q2 2025 at 342,885 shares (US$3.2M). The position peaked in Q2 2026 at 427,885 shares, worth US$12.7M. Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 427,885 shares valued at US$8.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 342.88K | $3.19M | New |
| Q3 2025 | 384.88K | $6.08M | Add |
| Q4 2025 | 372.38K | $6.27M | Reduce |
| Q1 2026 | 427.88K | $8.51M | Add |
| Q2 2026 | 427.88K | $12.70M | Hold |
| Q3 2026 | 427.88K | $7.96M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCAX and 13F data
BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Vestal Point Capital, LP (US$155.9M), Deep Track Capital, LP (US$121.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCAX
- RA CAPITAL MANAGEMENT, L.P. 7.26M sh · $215.43M · Q2 2026
- Vestal Point Capital, LP 5.25M sh · $155.87M · Q2 2026
- Deep Track Capital, LP 4.10M sh · $121.73M · Q2 2026
- Siren, L.L.C. 5.50M sh · $102.41M · Q3 2026
- TPG GP A, LLC 3.01M sh · $89.38M · Q2 2026
- Red Tree Management, LLC 2.92M sh · $54.35M · Q3 2026
- Omega Fund Management, LLC 1.82M sh · $54.10M · Q2 2026
- Jones Hill Capital LP 1.06M sh · $19.81M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 643.38K sh · $19.10M · Q2 2026
- Palo Alto Investors LP 550.41K sh · $16.34M · Q2 2026
- Rock Springs Capital Management LP 535.29K sh · $15.89M · Q2 2026
- Aisling Capital Management LP 548.92K sh · $10.22M · Q3 2026
More on NAN FUNG TRINITY (HK) Ltd
FAQ
How long has NAN FUNG TRINITY (HK) Ltd held BCAX?
NAN FUNG TRINITY (HK) Ltd has disclosed BCAX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is NAN FUNG TRINITY (HK) Ltd's current position in BCAX?
As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 427.88K shares of BCAX (BICARA THERAPEUTICS INC), valued at $7.96M, representing 0.76% of its reported portfolio and ranking #44.
Has NAN FUNG TRINITY (HK) Ltd been buying or selling BCAX?
In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in BCAX. The position peaked in Q2 2026 at 427.88K shares.
Which other funds hold BCAX?
Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Deep Track Capital, LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.